Evidence-based·Last reviewed June 1, 2026·How we grade evidence

Flavin mononucleotide

VitaminB2

The phosphorylated coenzyme form of riboflavin (vitamin B2). FMN is what the body uses directly inside cells, and it's the preferred form for IV/IM clinical injections because of better water solubility. However, oral FMN is hydrolyzed back to riboflavin in the gut before absorption — so 'activated B2' marketing for oral capsules doesn't translate to a real bioavailability advantage. The generic B2 facts (deficiency correction, migraine prevention, MTHFR-related uses) live on the riboflavin and vitamin-b2 pages.

Quick decision guide

May help most

Parenteral (IV/IM) B2 replacement in clinical settings where solubility matters. As an oral supplement, FMN offers no proven advantage over plain riboflavin — pick riboflavin unless a specific clinician recommends FMN.

Common dosing range

Oral (where used): 5–25 mg FMN per day, often as part of an activated B-complex. Parenteral: 5–10 mg FMN-sodium IV/IM in clinical replacement therapy. Migraine prevention dose (riboflavin form, not FMN-tested): 400 mg/day.

When to expect effects

Hours for tissue uptake from parenteral use; days to weeks for oral replacement of deficiency.

Watch out for

Oral 'activated B2' marketing implies better absorption than riboflavin — the gut-dephosphorylation evidence (Hustad 2002, ODS) doesn't support this. Don't pay a premium for oral FMN expecting absorption benefit.

Evidence snapshot

Parenteral B2 replacement (clinical)Moderate
Coenzyme function (mechanism)Established
Oral absorption advantage vs riboflavinNot supported
Migraine prevention (FMN-specific)Untested at 400 mg

What is it

Flavin mononucleotide (FMN, also called riboflavin 5'-phosphate) is the active coenzyme form of vitamin B2 (riboflavin). It is used directly by enzymes in energy metabolism.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You're receiving IV or IM B2 in a clinical setting — FMN-sodium is the standard parenteral form because it's water-soluble
Your clinician has specifically prescribed FMN over riboflavin for a particular reason (some choose it for activated B-complex formulations)
You have a rare flavin metabolism disorder where the form choice has been individualized by a metabolic specialist
You want a B-complex that uses coenzyme forms across the board (5-MTHF, methylcobalamin, P5P, FMN) for ideological consistency — recognizing the oral absorption advantage is theoretical

Probably skip if…

You want better oral absorption than plain riboflavin — gut dephosphorylation means oral FMN and oral riboflavin enter circulation the same way
You're trying to prevent migraine — the only well-established dose is 400 mg/day riboflavin (Schoenen 1998); FMN hasn't been tested at that dose
You're paying a 3–5× premium over a generic riboflavin tablet for 'activated' B2 — the evidence doesn't support the markup for oral use
You're simply correcting a B2 deficiency — plain riboflavin works as well at a fraction of the cost

Evidence at a glance

Coenzyme function (mechanism, not endpoint)

Strong Evidence
Effect
Required cofactor for ~100+ flavoenzymes; conversion of riboflavin to FMN occurs efficiently in tissues
Best fit
Everyone needs adequate riboflavin/FMN — the question is whether the supplement form matters
Time
N/A (mechanistic claim)

Parenteral B2 replacement (clinical setting)

Good Evidence
Effect
Enables injection at therapeutic concentrations that riboflavin base cannot achieve
Best fit
Hospital inpatients on parenteral nutrition, post-bariatric patients with severe malabsorption, severe alcohol-use-disorder patients receiving B-complex injections
Time
Hours (parenteral)

Migraine prevention (not FMN-specific)

Limited Evidence
Effect
≥50% reduction in migraine attack frequency in 59% of patients on 400 mg/day riboflavin vs 15% on placebo (Schoenen 1998)
Best fit
If considering this for migraine, use the well-studied riboflavin form at 400 mg/day, not FMN
Time
≥3 months in migraine trials

Oral 'activated B2' bioavailability advantage

Mixed Evidence
Effect
No measurable oral-bioavailability advantage over riboflavin in published data
Best fit
None for the absorption claim specifically — pick riboflavin for oral use
Time
Not established for oral FMN-specific endpoints

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Coenzyme function (mechanism, not endpoint)

Mechanism only
Strong Evidence

FMN is one of the two active coenzyme forms of riboflavin (the other being FAD). It serves as the prosthetic group in numerous flavoprotein oxidoreductases — most notably NADH dehydrogenase (complex I of the electron transport chain), and enzymes involved in folate, methionine, vitamin B6, and tryptophan metabolism. This biochemical role is established and not in dispute. The relevant question for supplementation is whether starting with oral FMN delivers a meaningful advantage over starting with oral riboflavin — and that's where the evidence is thin.

Effect size
Required cofactor for ~100+ flavoenzymes; conversion of riboflavin to FMN occurs efficiently in tissues
Time to effect
N/A (mechanistic claim)
Best fit
Everyone needs adequate riboflavin/FMN — the question is whether the supplement form matters
Less likely
Anyone hoping the cofactor role translates to an oral-absorption or clinical-outcome advantage for FMN vs riboflavin

Bottom line: FMN is essential biochemistry; that doesn't translate to a clear advantage for oral FMN supplements over riboflavin.

SourceFlavin Mononucleotide (PubChem CID 643976) — PubChemNIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODS

Parenteral B2 replacement (clinical setting)

Supplement benefit
Good Evidence

Riboflavin base has limited water solubility (~120 mg/L at 25°C), which makes it unsuitable for IV or IM injection at typical replacement doses. FMN-sodium is much more soluble and is the standard form in pharmaceutical injectable preparations. Used in hospital pharmacology for parenteral nutrition formulations, post-bariatric malabsorption support, and acute Wernicke prevention regimens (alongside thiamine). This is the one clinical setting where 'FMN vs riboflavin' has a clear answer — solubility wins.

Effect size
Enables injection at therapeutic concentrations that riboflavin base cannot achieve
Time to effect
Hours (parenteral)
Best fit
Hospital inpatients on parenteral nutrition, post-bariatric patients with severe malabsorption, severe alcohol-use-disorder patients receiving B-complex injections
Less likely
Outpatient consumers who can swallow tablets — oral riboflavin is fine here

Bottom line: Real advantage in clinical injectables; not relevant to consumer oral supplements.

SourceEMA — Riboflavin (Vitamin B2) Monograph — European Medicines AgencyFlavin Mononucleotide (PubChem CID 643976) — PubChem

Migraine prevention (not FMN-specific)

Supplement benefit
Limited Evidence

High-dose riboflavin 400 mg/day reduces migraine frequency in adults (Schoenen 1998, PMID 9484373 — 59% achieved ≥50% attack reduction vs 15% on placebo, p<0.01; later trials replicated this for adults). The trials all used riboflavin base, not FMN. FMN has not been tested at the 400 mg/day migraine dose. Given gut-dephosphorylation, it's unlikely FMN would outperform riboflavin in this indication. The riboflavin and vitamin-b2 pages cover this in depth.

Effect size
≥50% reduction in migraine attack frequency in 59% of patients on 400 mg/day riboflavin vs 15% on placebo (Schoenen 1998)
Time to effect
≥3 months in migraine trials
Best fit
If considering this for migraine, use the well-studied riboflavin form at 400 mg/day, not FMN
Less likely
FMN as a migraine-specific alternative — untested at the relevant dose

Bottom line: Migraine prevention evidence is for riboflavin, not FMN. Use riboflavin 400 mg/day if pursuing this.

SourceSchoenen et al., 1998 — High-dose riboflavin for migraine prevention — PubMed — NeurologyNIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODS

Oral 'activated B2' bioavailability advantage

Mixed Evidence

The marketing claim is that oral FMN (riboflavin-5'-phosphate) skips an activation step the body has to perform on plain riboflavin, giving better tissue uptake. The biochemical problem: alkaline phosphatase in the gut lining hydrolyzes the 5'-phosphate group from FMN before absorption, so FMN enters circulation as plain riboflavin — the same as if you took riboflavin to begin with. Hustad et al. 2002 (PMID 12089174) and the NIH ODS factsheet both note this. No head-to-head RCT has shown oral FMN beats oral riboflavin on any clinical or biomarker endpoint. The 'activation' that matters happens inside cells, not in the supplement bottle.

Effect size
No measurable oral-bioavailability advantage over riboflavin in published data
Time to effect
Not established for oral FMN-specific endpoints
Best fit
None for the absorption claim specifically — pick riboflavin for oral use
Less likely
Anyone paying a premium for oral FMN expecting absorption benefit

Bottom line: Don't pay a premium for oral FMN expecting better absorption than riboflavin — the gut hydrolyzes the phosphate off before it gets absorbed.

Evidence is mixed

'Activated B-complex' marketing positions FMN as superior to riboflavin orally. The biochemistry of gut dephosphorylation and the NIH ODS / Hustad data don't support an oral absorption advantage. FMN-Na in injectables is a real solubility advantage; oral capsules don't share it.

SourceNIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODS· conflictingHustad et al., 2002 — Riboflavin and FMN as urinary excretion biomarkers — PubMed — Clin Chem· conflicting
SourceNIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODSHustad et al., 2002 — Riboflavin and FMN as urinary excretion biomarkers — PubMed — Clin Chem

How it works

FMN is derived from riboflavin by phosphorylation. It is a cofactor for flavin-dependent enzymes involved in the electron transport chain, fatty acid oxidation, and detoxification reactions. Supplementing with FMN bypasses the first phosphorylation step that converts riboflavin to FMN, which can be helpful in rare riboflavin metabolism disorders.

How to take it

1. Typical dose
• Oral (where used): 5–25 mg FMN per day, typically as part of an 'activated' B-complex • Parenteral (clinical only): 5–10 mg FMN-sodium IV/IM per day in replacement protocols • If your goal is general B2 adequacy: 1.1–1.3 mg/day riboflavin (the RDA) is plenty — and plain riboflavin works as well as FMN orally • For migraine prevention: use riboflavin 400 mg/day (the studied dose), not FMN
2. Higher studied dose
Parenteral FMN-sodium up to 50 mg/day has been used in hospital replacement regimens. Oral doses above 25 mg of FMN are not common; the body excretes excess riboflavin in urine (bright yellow color) without harm.
3. Timing
Oral B2 (FMN or riboflavin) is best absorbed with food — fat-containing meals slightly improve absorption. Splitting across the day modestly improves tissue uptake at high doses (>100 mg). Parenteral use is timed to clinical protocol.
4. With food
With food.
5. Split dosing
Single daily dose is fine at typical 5–25 mg oral intakes. Split dosing at high (>100 mg) intakes modestly improves absorption.
6. How long to try
Long-term as part of a B-complex is safe. Recheck the cost-benefit if you're paying a premium for FMN over riboflavin in oral form.

What to track

Bright yellow urine (harmless — indicates riboflavin is being absorbed and excreted)
Migraine frequency if using riboflavin 400 mg/day for prevention (not FMN-specific)
Tongue, lip, or skin signs of B2 deficiency (cheilitis, glossitis) — these should resolve on adequate intake
Cost — if you're paying a meaningful premium for oral FMN vs riboflavin, you're not getting a measurable benefit

Bottom line: For oral supplementation, pick riboflavin — it's cheaper and works as well. FMN's real advantage is in parenteral medicine; don't pay extra for it in capsules.

5 commercial forms

Compare the main delivery options and what they’re best suited for.

Riboflavin (vitamin B2 base)

Standard / most-evidence

The standard form used in supplements, food fortification, and all published clinical trials (including the Schoenen 400 mg/day migraine trial). Cheap and effective. The right oral form to use unless a clinician specifies otherwise.

Reference oral form; gut-absorbed efficiently up to ~30 mg per dose.

Flavin mononucleotide (FMN, oral)

Marketed 'activated B2'

Riboflavin with a 5'-phosphate group attached. Marketed as 'activated' for oral absorption; gut alkaline phosphatase removes the phosphate before uptake, so it enters circulation as plain riboflavin. Costs more than riboflavin without demonstrated oral advantage.

Dephosphorylated to riboflavin before gut absorption.

Flavin mononucleotide sodium (FMN-Na, injectable)

Clinical IV/IM use

Water-soluble sodium salt used in hospital IV/IM B-complex preparations, parenteral nutrition, and severe-malabsorption protocols. This is where FMN's solubility advantage matters; consumer oral capsules don't benefit from it.

100% bioavailable parenterally; not a consumer form.

Flavin adenine dinucleotide (FAD)

Other active coenzyme

The second active coenzyme form of B2, found in foods and used by many flavoproteins. Like FMN, oral FAD is hydrolyzed to riboflavin in the gut before absorption. Not commonly available as a single-ingredient supplement.

Also dephosphorylated to riboflavin orally.

Food sources (organ meats, dairy, eggs, leafy greens)

Whole-food source

Riboflavin in food occurs primarily as FMN and FAD bound to proteins; digestion releases free riboflavin for absorption. Liver, dairy, eggs, almonds, mushrooms, and leafy greens are top sources. Adequate dietary intake makes single-ingredient B2 supplementation unnecessary for most people.

Food-bound FMN/FAD released as riboflavin during digestion.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

bright yellow urine (harmless and expected)no notable side effects at standard dosesrare GI upset at very high oral doses

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Riboflavin (and FMN as a riboflavin source) is safe in pregnancy at the RDA (1.4 mg/day in pregnancy, 1.6 mg/day during lactation). FMN-Na is sometimes used in parenteral nutrition during pregnancy when oral intake isn't feasible. There are no established pregnancy concerns for B2 in either form at typical intakes.

SourceNIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODS

Bottom line: B2 in either form (riboflavin or FMN) has an excellent safety profile. Yellow urine is harmless. No UL has been needed.

Interactions

tetracycline antibiotics (doxycycline, minocycline)Minor

Riboflavin and FMN can theoretically reduce tetracycline absorption when taken simultaneously. Separate dosing by 2 hours if both are needed. Clinical significance is minor.

SourceNIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODS
phenobarbital and other CYP-inducing anticonvulsantsMinor

These drugs may increase riboflavin metabolism and lower B2 status over time. Higher intake of riboflavin (or FMN) may be needed in long-term anticonvulsant therapy.

SourceNIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODS
boric acid (chelation)Minor

Boric acid can chelate riboflavin and increase its urinary loss; clinical relevance is mainly historical and applies to specific occupational exposures, not typical use.

SourceNIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODS

Food sources

Beef liver, cooked

Amount
3 oz (2.91 mg)
%DV
224%

Breakfast cereal, fortified

Amount
1 serving (1.7 mg)
%DV
131%

Oats, fortified instant, cooked

Amount
1 cup (1.1 mg)
%DV
85%

Yogurt, plain low-fat

Amount
1 cup (0.57 mg)
%DV
44%

Milk, 2% fat

Amount
1 cup (0.45 mg)
%DV
35%

Beef, ground, 85% lean, broiled

Amount
3 oz (0.18 mg)
%DV
14%

Almonds, dry-roasted

Amount
1 oz (0.32 mg)
%DV
25%

Egg, hard-boiled

Amount
1 large (0.26 mg)
%DV
20%

Cheddar cheese

Amount
1.5 oz (0.18 mg)
%DV
14%

Spinach, boiled

Amount
½ cup (0.21 mg)
%DV
16%

Salmon, sockeye, cooked

Amount
3 oz (0.14 mg)
%DV
11%

Mushrooms, white, sliced, raw

Amount
½ cup (0.16 mg)
%DV
12%

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Look for 'flavin mononucleotide,' 'riboflavin-5'-phosphate,' 'FMN,' or 'FMN-sodium' on the label — confirms the coenzyme form
Stated mg of FMN (the molecule weighs ~456 g/mol vs riboflavin's 376 g/mol, so 1 mg FMN delivers ~0.82 mg riboflavin equivalents)
For migraine prevention, choose plain riboflavin 400 mg tablets (the studied form); FMN is unnecessary at that dose and unstudied
Third-party tested (USP, NSF, ConsumerLab) — confirms identity and label-claim accuracy
If buying an activated B-complex (5-MTHF, methylcobalamin, P5P, FMN), recognize the oral activation argument is theoretical — pay accordingly

Be skeptical of…

'Bypasses B2 conversion' or '5× better absorbed' claims — biochemistry of gut dephosphorylation makes this implausible orally
Mega-dose oral FMN marketed for migraine prevention at premium prices — use riboflavin instead
Anti-aging or 'cellular energy' claims beyond the basic riboflavin role in the electron transport chain — these are mechanism-only
'Liver detox' or 'methylation support' bundles charging a premium for FMN over riboflavin without disclosing the cost differential

Frequently asked questions

Is FMN better than riboflavin?⌄

For most people, regular riboflavin is converted to FMN efficiently and is just as effective. FMN may be helpful for rare metabolic conditions.

Why does it turn my urine yellow?⌄

That's a harmless effect of riboflavin's bright yellow color. Excess is excreted in urine.

References by claim

Coenzyme function (mechanism, not endpoint)

NIH Office of Dietary Supplements — Riboflavin (Health Professional) — NIH ODS (2024) link

Flavin Mononucleotide (PubChem CID 643976) — PubChem (2024) link

Oral 'activated B2' bioavailability advantage

Hustad et al., 2002 — Riboflavin and FMN as urinary excretion biomarkers — PubMed — Clin Chem (2002) link

Migraine prevention (not FMN-specific)

Schoenen et al., 1998 — High-dose riboflavin for migraine prevention — PubMed — Neurology (1998) link

Parenteral B2 replacement (clinical setting)

EMA — Riboflavin (Vitamin B2) Monograph — European Medicines Agency (2020) link

Other references

Flavin mononucleotide on Wikidata — Wikidata link

FMN (ChEBI:17621) — ChEBI link

Track Flavin mononucleotide with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed Jun 1, 2026·Evidence current as of Jun 1, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.